Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,133.12
(
-0.08%
)
US TECH 100
26,433.40
(
0.50%
)
Dow Jones
48,834.77
(
-0.63%
)
Brent Oil
111.06
(
6.37%
)
Bitcoin
75,620.54
(
-0.95%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122906
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: semi_infinite post# 212512

Wednesday, 03/28/2018 4:47:38 PM

Wednesday, March 28, 2018 4:47:38 PM

Post# of 257465
PSDV—>EYPT (EyePoint Pharmaceuticals) via reverse merger with private, Icon Bioscience, plus third-party financing:

https://globenewswire.com/news-release/2018/03/28/1455043/0/en/pSivida-Corp-Announces-Transformative-Acquisition-of-Icon-Bioscience-Inc-and-Growth-Capital-Financing-with-Essex-Woodlands-Healthcare-Partners-Company-Will-Rebrand-as-EyePoint-Phar.html

EyePoint Pharmaceuticals will trade under the new NASDAQ ticker symbol “EYPT” effective April 2, 2018. The former ticker symbol “PSDV” will remain effective through the market close on March 29, 2018. The new website for EyePoint Pharmaceuticals is www.eyepointpharma.com.

CC tomorrow at 8am ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (4) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (4) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today